EORTC protocol 08853

Phase II trial of cisplatin-etoposide combination in recurrent or metastatic invasive thymoma
Trial StatusAll trial activities ended
DatesDate of activation: 01-Jul-85
Closed on : 01-Aug-91
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size20
Number of steps1
Drug
Study StaffGiuseppe Giaccone (Study Coordinator) - National Cancer Institute - National Institute of Health, Bethesda
Type of cancerLung
Participating GroupsEORTC Lung Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section